Plasma Concentrations, Efficacy and Safety of Efavirenz in HIV-Infected Adults Treated for Tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA Trial).

Hdl Handle:
http://hdl.handle.net/10144/315018
Title:
Plasma Concentrations, Efficacy and Safety of Efavirenz in HIV-Infected Adults Treated for Tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA Trial).
Authors:
Borand, Laurence; Madec, Yoann; Laureillard, Didier; Chou, Monidarin; Marcy, Olivier; Pheng, Phearavin; Prak, Narom; Kim, Chindamony; Lak, Khemarin Kim; Hak, Chanroeun; Dim, Bunnet; Nerrienet, Eric; Fontanet, Arnaud; Sok, Thim; Goldfeld, Anne E; Blanc, François-Xavier; Taburet, Anne-Marie
Journal:
PloS ONE
Abstract:
To assess efavirenz plasma concentrations and their association with treatment efficacy and tolerance of efavirenz 600 mg daily in HIV-tuberculosis co-infected patients.
Publisher:
Public Library of Science
Issue Date:
2014
URI:
http://hdl.handle.net/10144/315018
DOI:
10.1371/journal.pone.0090350
PubMed ID:
24608960
Language:
en
ISSN:
1932-6203
Appears in Collections:
HIV/AIDS

Full metadata record

DC FieldValue Language
dc.contributor.authorBorand, Laurenceen_GB
dc.contributor.authorMadec, Yoannen_GB
dc.contributor.authorLaureillard, Didieren_GB
dc.contributor.authorChou, Monidarinen_GB
dc.contributor.authorMarcy, Olivieren_GB
dc.contributor.authorPheng, Phearavinen_GB
dc.contributor.authorPrak, Naromen_GB
dc.contributor.authorKim, Chindamonyen_GB
dc.contributor.authorLak, Khemarin Kimen_GB
dc.contributor.authorHak, Chanroeunen_GB
dc.contributor.authorDim, Bunneten_GB
dc.contributor.authorNerrienet, Ericen_GB
dc.contributor.authorFontanet, Arnauden_GB
dc.contributor.authorSok, Thimen_GB
dc.contributor.authorGoldfeld, Anne Een_GB
dc.contributor.authorBlanc, François-Xavieren_GB
dc.contributor.authorTaburet, Anne-Marieen_GB
dc.date.accessioned2014-03-31T20:53:25Z-
dc.date.available2014-03-31T20:53:25Z-
dc.date.issued2014-
dc.identifier.citationPlasma Concentrations, Efficacy and Safety of Efavirenz in HIV-Infected Adults Treated for Tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA Trial). 2014, 9 (3):e90350 PLoS ONEen_GB
dc.identifier.issn1932-6203-
dc.identifier.pmid24608960-
dc.identifier.doi10.1371/journal.pone.0090350-
dc.identifier.urihttp://hdl.handle.net/10144/315018-
dc.description.abstractTo assess efavirenz plasma concentrations and their association with treatment efficacy and tolerance of efavirenz 600 mg daily in HIV-tuberculosis co-infected patients.en_GB
dc.language.isoenen
dc.publisherPublic Library of Scienceen_GB
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen_GB
dc.subjectHIV/AIDSen_GB
dc.subjectTuberculosisen_GB
dc.titlePlasma Concentrations, Efficacy and Safety of Efavirenz in HIV-Infected Adults Treated for Tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA Trial).en
dc.identifier.journalPloS ONEen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.